| PCMA Comments_ICR IPAY Proposed Forms_CMS-10912_12-20-24_FINAL..pdf | |
| PCMA Comments on Medicare Two Dollar Drug List Model RFI 9December2024[13].pdf | |
| PCMA Prerule Comments for CY 2026 Rulemaking and Guidance November 1, 2024.pdf | |
| PCMA comments on ICR-IPAY 2027 - September 3 2024.pdf | |
| PCMA comments on Considerations in Demonstrating Interchangeability With a Reference Product Update_ Draft Guidance for Industry_ August 20 2024.pdf | |
| PCMA comments on USPTO Terminal Disclaimer Practice - July 9 2024.pdf | |
| PCMA comments on IPAY 2027 - July 2 2024.pdf | |
| PCMA comments on M3P Model Docs - CMS 10882 PCMA - June 27, 2024.pdf | |
| PCMA comments on CMS-10185 30-day PRA - June 24 2024.pdf | |
| PCMA Comments on HHS FTC RFI Drug Shortage - May 30 2024.pdf | |
| PCMA comments on MA RFI - May 29 2024.pdf | |
| PCMA comments on Medicare Prescription Payment Plan Part Two - March 15, 2024.pdf | |
| PCMA comments on Medicare Part D Reporting Requirements ICR - CMS-10185 - April 2 2024.pdf | |
| PCMA comments on 2023 RxDC Reporting Instructions - April 1 2024.pdf | |
| PCMA comments on MARx System Updates for M3P - March 26 2024.pdf | |
| PCMA comments on CY2025 Part D Benefit Redesign - March 1, 2024.pdf | |
| PCMA comments on NBPP 2025 Proposed Rule - January 8 2024.pdf | |
| PCMA comments on CMS 4205P CY2025 Part D rule - January 4 2024.pdf | |
| PCMA comments on Info Blocking Disincentives proposed rule - January 2 2024.pdf | |
